Mylan's generic of cholesterol drug Crestor gets tentative FDA nod

07/10/2013 | Drug Store News

Mylan received tentative FDA approval for its cholesterol-lowering treatment rosuvastatin calcium. The treatment, available in 40 mg, 20 mg, 10 mg and 5 mg tablets, is a generic copy of AstraZeneca's Crestor.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID